Kamal Hamed

Kamal Hamed

Plus aucun poste en cours
65 ans
Health Technology
Consumer Services

Profil

Kamal Hamed currently works at Spero Therapeutics, Inc., as Chief Medical Officer from 2022.
Dr. Hamed also formerly worked at Novartis, Inc., as Head-Therapeutic Area from 2005 to 2017, Basilea Pharmaceutica AG, as Head-Clinical Development & Medical Affairs from 2017 to 2022, and Lysovant Sciences, Inc., as Chief Medical Officer in 2022.
Dr. Hamed received his graduate degree from The Johns Hopkins University, Masters Business Admin degree from the University of South Florida, and doctorate degree from American University of Beirut.

Anciens postes connus de Kamal Hamed

SociétésPosteFin
SPERO THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 01/08/2024
Lysovant Sciences, Inc.
Directeur Technique/Scientifique/R&D 01/08/2022
BASILEA PHARMACEUTICA AG Directeur Technique/Scientifique/R&D 01/02/2022
Corporate Officer/Principal 01/03/2017
Voir l'expérience en détail de Kamal Hamed

Formation de Kamal Hamed

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

9

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées7

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Lysovant Sciences, Inc.

  1. Bourse
  2. Insiders
  3. Kamal Hamed